Join to View Full Profile
3280 N McMullen Booth RdSte 120Clearwater, FL 33761
Phone+1 727-789-8770
Fax+1 727-789-8784
Dr. Tolentino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1994 - 1999
Mount Auburn HospitalInternship, Internal Medicine, 1993 - 1994
University of Massachusetts Medical SchoolClass of 1993
Certifications & Licensure
FL State Medical License 2004 - 2027
MA State Medical License 1998 - 2005
PA State Medical License 1999 - 2004
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
- A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration.Valory Anne S Vailoces, Andrew J Tolentino, Jose Fernando Arevalo, Ron A Adelman, Robert Bhisitkul
Pharmaceuticals. 2025-04-29 - Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity.Husam Nawafleh, Nagwa Zeinelabdin, Michelle K Greene, Anitha Krishnan, Linus Ho
Pharmaceuticals. 2024-10-28 - 5 citationsPolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular ...Sheri L Peterson, Anitha Krishnan, Diyan Patel, Ali Khanehzar, Amit Lad
Pharmaceuticals. 2024-04-17
Press Mentions
Aviceda Therapeutics : Announces Strategic Alliance with University of GeorgiaSeptember 27th, 2021- Aviceda Therapeutics Announces Formation of Executive TeamJanuary 11th, 2021
Michael J. Tolentino, MD, Ophthalmologist, Retinal Specialist – Surgeon with the Macula CenterMay 13th, 2019- Join now to see all
Grant Support
- Mechanism Of Mutant TIMP-3 Induced NeovascularizationNational Eye Institute2001–2004
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
